Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors
- PMID: 17979880
- PMCID: PMC4401270
- DOI: 10.1111/j.1582-4934.2007.00120.x
Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors
Abstract
There is now accumulating evidence that bone marrow-derived mesenchymal stem cells (MSCs) make an important contribution to postnatal vasculogenesis, especially during tissue ischaemia and tumour vascularization. Identifying mechanisms which regulate the role of MSCs in vasculogenesis is a key therapeutic objective, since while increased neovascularization can be advantageous during tissue ischaemia, it is deleterious during tumourigenesis. The potent angiogenic stimulant vascular endothelial growth factor (VEGF) is known to regulate MSC mobilization and recruitment to sites of neovascularization, as well as directing the differentiation of MSCs to a vascular cell fate. Despite the fact that MSCs did not express VEGF receptors, we have recently identified that VEGF-A can stimulate platelet-derived growth factor (PDGF) receptors, which regulates MSC migration and proliferation. This review focuses on the role of PDGF receptors in regulating the vascular cell fate of MSCs, with emphasis on the function of the novel VEGF-A/PDGF receptor signalling mechanism.
Figures



Similar articles
-
Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch.Blood. 2010 Oct 21;116(16):2984-93. doi: 10.1182/blood-2010-02-269894. Epub 2010 Jul 6. Blood. 2010. PMID: 20606160 Free PMC article.
-
Mesenchymal stromal cells: inhibiting PDGF receptors or depleting fibronectin induces mesodermal progenitors with endothelial potential.Stem Cells. 2014 Mar;32(3):694-705. doi: 10.1002/stem.1538. Stem Cells. 2014. PMID: 24022915 Free PMC article.
-
Platelet-derived growth factor receptors regulate mesenchymal stem cell fate: implications for neovascularization.Expert Opin Biol Ther. 2010 Jan;10(1):57-71. doi: 10.1517/14712590903379510. Expert Opin Biol Ther. 2010. PMID: 20078229 Review.
-
Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.Arthritis Rheum. 2007 Jun;56(6):1994-2004. doi: 10.1002/art.22698. Arthritis Rheum. 2007. PMID: 17530639
-
Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis.J Intern Med. 2018 Jan;283(1):16-44. doi: 10.1111/joim.12690. Epub 2017 Oct 17. J Intern Med. 2018. PMID: 28940884 Review.
Cited by
-
Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion.Mol Vis. 2010 Apr 3;16:586-95. Mol Vis. 2010. PMID: 20376327 Free PMC article.
-
Comparative analysis of gene transcripts for cell signaling receptors in bone marrow-derived hematopoietic stem/progenitor cell and mesenchymal stromal cell populations.Stem Cell Res Ther. 2013 Sep 16;4(5):112. doi: 10.1186/scrt323. Stem Cell Res Ther. 2013. PMID: 24405801 Free PMC article.
-
Mesenchymal stem cells improve healing of the cornea after alkali injury.Graefes Arch Clin Exp Ophthalmol. 2015 Jul;253(7):1121-35. doi: 10.1007/s00417-015-3042-y. Epub 2015 May 23. Graefes Arch Clin Exp Ophthalmol. 2015. PMID: 26002143
-
PDGF enhances the protective effect of adipose stem cell-derived extracellular vesicles in a model of acute hindlimb ischemia.Sci Rep. 2018 Dec 4;8(1):17458. doi: 10.1038/s41598-018-36143-3. Sci Rep. 2018. PMID: 30514962 Free PMC article.
-
Multipotent Mesenchymal Stromal Cells for Autoimmune Diseases.Transfus Med Hemother. 2008;35(4):313-318. doi: 10.1159/000140859. Epub 2008 Jul 17. Transfus Med Hemother. 2008. PMID: 21512648 Free PMC article.
References
-
- Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult mesenchymal stem cells. Science. 1999;284:143–7. - PubMed
-
- Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, Branco RV, Oliveira EM, He R, Geng Y-J, Willerson JT, Perin EC. Mesenchymal stem cells differentiate into a endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation. 2005;111:150–6. - PubMed
-
- Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M, Yamagishi M, Mori H, Kangawa K, Kitamura S. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol. 2004;287:H2670–6. - PubMed
-
- Annabi B, Naud E, Lee Y-T, Eliopoulos N, Galipeau J. Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors. J Cell Biochem. 2004;91:1146–58. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources